Wellcome Trust Rapid Response

Wellcome Trust Rapid Response
Name	Wellcome Trust Rapid Response
Type	Research funding mechanism
Founded	2020
Founder	Wellcome Trust
Headquarters	London
Area served	Global
Key people	Jeremy Farrar, Tony Bellew, Salah Al-Din

Wellcome Trust Rapid Response The Wellcome Trust Rapid Response is a time-limited emergency funding mechanism established by the Wellcome Trust to accelerate research during public health crises, supporting rapid projects spanning biomedical science, clinical medicine, epidemiology, and data science; it was created in response to urgent threats such as the COVID-19 pandemic and aims to complement longstanding programmes like the Wellcome Leap and collaborations with organisations such as the World Health Organization, UK Research and Innovation, and the Bill & Melinda Gates Foundation.

Background and Purpose

The scheme emerged amid global crises including the COVID-19 pandemic, the Ebola epidemic in West Africa, and the Zika virus outbreak, reflecting priorities set by funders such as the Wellcome Trust, Gates Foundation, and Coalition for Epidemic Preparedness Innovations to support rapid translational work, strengthen surveillance with partners like the Centers for Disease Control and Prevention and the European Centre for Disease Prevention and Control, and bridge gaps between institutions such as Imperial College London, University of Oxford, and the London School of Hygiene & Tropical Medicine.

Funding Mechanisms and Eligibility

Funding rounds typically allocate awards to researchers at organisations including King's College London, University College London, Harvard University, Johns Hopkins University, and national institutes like the National Institutes of Health and the Karolinska Institutet. Eligible applicants often include principal investigators affiliated with higher education institutions, research hospitals such as Great Ormond Street Hospital, and consortia involving NGOs like Médecins Sans Frontières and public health agencies including the National Health Service. The mechanism provides flexible budgets for activities ranging from laboratory research at centres such as the Francis Crick Institute to field epidemiology programmes in partnership with entities like the Africa Centres for Disease Control and Prevention.

Application and Review Process

Applications are typically fast-tracked through peer review panels drawing reviewers from organisations such as Wellcome Trust, Royal Society, Academy of Medical Sciences, and international expert networks including the European Molecular Biology Laboratory; reviewers include specialists from institutions such as Broad Institute, Scripps Research, and ETH Zurich. Timelines compress standard processes used by funders like National Science Foundation and European Research Council, employing rapid ethics checks with committees akin to those at UK Research and Innovation and expedited contracting models observed with partners including the Bill & Melinda Gates Foundation and the Wellcome Sanger Institute.

Notable Awards and Impact

Awardees have included consortia led by researchers at University of Cambridge, University of Edinburgh, Peking University, and Karolinska Institutet that contributed to diagnostics, therapeutics, and modelling used by agencies such as the World Health Organization and the European Centre for Disease Prevention and Control. Projects funded under the mechanism have supported vaccine research linked to entities like AstraZeneca, therapeutic trials coordinated with National Institutes of Health networks, and genomic surveillance partnerships with sequencing centres including the Wellcome Sanger Institute and the Broad Institute, influencing responses to outbreaks recognized by the Nobel Prize community, the Lancet, and specialist journals such as Nature, Science, and The New England Journal of Medicine.

Governance and Partnerships

Governance integrates the Wellcome Trust board with advisory input from experts affiliated with institutions such as the Royal Society, Academy of Medical Sciences, World Health Organization, and funders like the Bill & Melinda Gates Foundation and UK Research and Innovation. Strategic partnerships have been formed with academic hubs such as Imperial College London, University of Oxford, public health bodies including the UK Health Security Agency, and international organisations like the Pan American Health Organization and the Africa Centres for Disease Control and Prevention, enabling coordination of multicentre trials, data sharing accords with repositories such as the European Nucleotide Archive, and collaborations with commercial partners like GlaxoSmithKline.

Criticisms and Controversies

Critiques echo concerns raised in debates involving the Wellcome Trust and other funders like the Gates Foundation: transparency about award selection akin to controversies around grants at institutions such as Harvard University and University of Oxford; tensions over intellectual property and partnerships with companies such as AstraZeneca and GlaxoSmithKline; and questions about equity in distribution across regions highlighted by advocates including Amnesty International and researchers from University of Cape Town and Makerere University. Observers from bodies like the House of Commons Health and Social Care Committee and commentators in outlets such as The Guardian and Financial Times have debated the balance between speed and rigorous peer review, echoing issues seen in emergency funding by organisations such as the National Institutes of Health and the European Research Council.

Category:Research funding organizations